COMMUNIQUÉS West-GlobeNewswire

-
Adamas Announces New Employment Inducement Grant
10/01/2019 -
Agile Therapeutics, Inc. Provides Regulatory Update and Reiterates Cash Guidance
10/01/2019 -
Cerner and Christiana Care Health System Work to Deliver Bariatric Services to Associates Through a Personalized, Supportive Experience
10/01/2019 -
Indiana Minority Health Coalition to Host “Change Your Lifestyle. Change Your Life” Diabetes Screenings on January 23
10/01/2019 -
Sarah Durham Named Chair of the National Brain Tumor Society Board of Directors
10/01/2019 -
How gaming and social media are designed to keep teenagers hooked: An evening event for gamers, parents and professionals with Cam Adair, hosted by The Sinneave Family Foundation
10/01/2019 -
PSI’s Acquisition of QuarterLine Strengthens its Position as a Health IT Leader
10/01/2019 -
GENFIT: HALF-YEAR REPORT OF LIQUIDITY CONTRACT WITH CIC
10/01/2019 -
GENFIT : BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITE CONTRACTE AVEC CIC
10/01/2019 -
EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as of December 31, 2018
10/01/2019 -
EssilorLuxottica : Nombre total de droits de vote et d'actions composant le capital social au 31 décembre 2018
10/01/2019 -
Holding(s) in Company
10/01/2019 -
ASCO and Tempus Announce Collaboration to Help Research Sites Identify Potential Participants for the Targeted Agent and Profiling Utilization (TAPUR™) Study
10/01/2019 -
EMA Grants Orphan Drug Designation to Rafael Pharmaceuticals’ devimistat (CPI-613®) for Treatment of Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML)
10/01/2019 -
Janis Romanovskis reelected to the Board of JSC “Grindeks”
10/01/2019 -
Cerner to Release Fourth Quarter 2018 Earnings Results February 5
10/01/2019 -
NRC Health Partners with TennCare to Improve Quality of Care and Resident Satisfaction in Medicaid Nursing Facilities Across Tennessee
10/01/2019 -
DLT Resolution Provides Digitization & Call Center Services to Large Canadian City
10/01/2019 -
Corvus Announces Presentation of Preclinical Data on CPI-818, a First-in-class Covalent Inhibitor of ITK Targeting T-Cell Lymphomas
10/01/2019
Pages